Hepatic Artery Chemoembolization for Hepatocellular Carcinoma Recurrence Confined to the Transplanted Liver

BACKGROUND: Careful hepatocellular carcinoma (HCC) case selection permits orthotopic liver transplantation with the expectation of around 70% plus 5-year survival. However, many patients have tumor recurrences and there is little literature guidance in the management of these patients. AIMS: A retro...

Descripción completa

Detalles Bibliográficos
Autor principal: Carr, Brian I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
September, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493104/
https://www.ncbi.nlm.nih.gov/pubmed/23139662
http://dx.doi.org/10.1159/000343043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493104/
https://www.ncbi.nlm.nih.gov/pubmed/23139662
http://dx.doi.org/10.1159/000343043

Ejemplares similares